clinical trial · NCT06848348
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic PainHalneuronPlacebo
brief summary
A randomized study to determine safety and efficacy of single subcutaneous (SC) administration of HAL treatment in patients with CINP.
started
Feb 21, 2025
primary completion
Jul 1, 2026
completion
Aug 1, 2026
last updated
Jan 12, 2026
official title
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol